Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
714619
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
||
|
FDA ORPHAN DRUG |
536316
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2461338
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
2135632-29-8
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
300000004884
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
FJZ07Q63VY
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
Atoltivimab
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
FG-87
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
C169793
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
11032
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY | |||
|
FJZ07Q63VY
Created by
admin on Mon Mar 31 23:11:32 GMT 2025 , Edited by admin on Mon Mar 31 23:11:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY